For Patients

Introduction

For surgical patients in timely needs of Omega-3 PUFAs supplementation. To reduce risks on SIRS due to excessive inflammatory reactions. Product is more rapidly absorbed, more enriched on cell membranes and more effective with its Omega-3 PUFAs. Therefore, the product reduces development of negative sequelae post surgery, and potentially reduces length of hospital stays, overall treatment cost and presents higher cost-effectiveness when used.

Appropriate Patients

Please CLICK on appropriate patient categories to see details

User Manual

User Manual will help you to better know FASTOMEGA™, and it provides you major knowledge you might want to know. Download and read it, you will know that FASTOMEGA™ is your best choice.

Download

FAQs

FASTOMEGA™ is a high-purity, concentrated omega-3 polyunsaturated fatty acids medical food that can be administered orally after dilution, directly through a nasogastric tube, or through a jejunum nutrition tube.

1. Usage and dosage for oral administration

Dosage before surgery: One to two pouches per day (120ml-240ml), divide into two times for oral administration. Recommended to be taken after meal (preferably after breakfast and dinner).

It`s recommended patients to start to use one to two pouches (120ml-240ml) per day from 7 days before surgery, or follow doctors or certified dieticians` dosage regimen, to rapidly improve the level of Omega-3 polyunsaturated fatty acids in the body.

Dosage after surgery: when patients are able to eat (liquid, semi-liquid, or normal food) after surgery, FASTOMEGATM can be used one to two pouches per day (120ml-240ml), divide into two times for oral administration for 14-21 days to ensure the effective enrichment of Omega-3 polyunsaturated fatty acids on cells membrane in organs, and it`s recommended to be taken after meal (preferably after breakfast and dinner).

Usage: After opening the cap of the flexible package, pour 60ml of FASTOMEGATM into the measuring cup, and add 60ml of water, gently stir for 10 seconds, then take it orally. Tighten the cap and save the remaining unused FASTOMEGATM for next use.

Opened FASTOMEGA™ need to be take completely within 24 hours, and it is NOT recommended to use if FASTOMEGA™ opened more than 24 hours.

2. The usage and dosage of nasogastric feeding

The dosage of before surgery: if patients can orally take it, please follow the instruction “1 Usage and dosage for oral administration”.

If it is necessary to use nasogastric feeding, take one pouch at a time with 20nl/hour dripping speed every day. It`s recommended to be used after having full nutrition food.

It`s recommended patients to start to use one to two pouches (120ml-240ml) per day from 7 days before surgery, or follow doctors or certified dieticians` dosage regimen, to rapidly improve the level of Omega-3 polyunsaturated fatty acids in the body.

Dosage for after surgery: When patients can take enteral nutrition feeding after surgery, FASTOMEGATM could be used one to two pouches per day with 20ml/hour dripping speed. It`s recommended to be used after having full nutrition food. Continuously use for 14-21 days to ensure a higher level of Omega-3 polyunsaturated fatty acids on cells membrane in organs.

Usage: after carefully opening the cap of the flexible package, connect with the conical joint (or capped joint) of the nasogastric feeding tube, make sure there is no leakage. Hang the flexible package upside down on the infusion rack (there is a hole on the flexible package). Then turn on the peristaltic pump and control the dripping rate at 20ml/hour for continuous use.

3. The usage and dosage of using jejunal nutrient tube:

Dosage before surgery: One to two pouches of FASTOMEGATM a day (120ml-240ml) divided into two times, and it`s recommended to be taken after meal (preferably after breakfast and dinner).

It`s recommended patients to start to use one to two pouches (120ml-240ml) per day from 7 days before surgery, or follow doctors or certified dieticians` dosage regimen, to rapidly improve the level of Omega-3 polyunsaturated fatty acids in the body.

Dosage after surgery: when patients are able to eat (liquid, semi-liquid, or normal food) after surgery, FASTOMEGATM can be used one to two pouches per day (120ml-240ml), divide into two times for administration for 14-21 days to ensure the effective enrichment of Omega-3 polyunsaturated fatty acids on cells membrane in organs in a higher level, and it`s recommended to be taken after meal (preferably after breakfast and dinner).

Usage: After opening the cap of the flexible package, pour 60ml of FASTOMEGATM into the measuring cup, and add 60ml of water, gently stir for 10 seconds with a stick, then use it. Tighten the cap and save the remaining unused FASTOMEGATM for next use.

Opened FASTOMEGA™ need to be take completely within 24 hours, and it is NOT recommended to use if FASTOMEGA™ opened more than 24 hours.

FASTOMEGA™ is a high purity content of Omega-3 polyunsaturated fatty acids preparations, mainly contains Omega-3 polyunsaturated fatty acids (DHA + EPA, comes from the deep-sea fish), medium chain fatty acids (MCT, from coconut oil and palm kernel oil). FASTOMEGA™ is a kind of medical food which is suitable for the elective surgery patients who need to quickly supplement Omega-3 polyunsaturated fatty acids. In general, taking high purity Omega-3 polyunsaturated fatty acids is beneficial to human health, but the following situation may occur, although the incidence is very low: (1) people who allergic to fish or seafood may also appear allergic symptoms; (2) may adjust the blood sugar level; (3) Omega-3 fatty acids can cause lower blood pressure, as a result, people who are taking hypotensive drugs may get a lower blood pressure when they take FASTOMEGA™.

In general, Omega-3 polyunsaturated fatty acids can cause the following adverse reactions: belching, halitosis, heartburn, nausea, loose stools, dizziness, rash and nosebleeds. However, when taking it after a meal can reduce these side effects. The adverse events associated with MCT include gastrointestinal symptoms (e.g., abdominal cramps, diarrhea, and indigestion). This may be due to the rapid hydrolysis of MCT in the intestine and the accumulation of high concentrations of medium chain fatty acids in the small intestine. Syncope and vertigo are rarely reported (<1/500), and patients with a history of bradycardia or hypotension, or who take drugs (such as antihypertensives and cholinesterase inhibitors) that may induce these effects.

  • FASTOMEGA™ containing MCTs, which contribute to enrichment of DHA and EPA more and faster in the human cell membrane, the enrichment is 1.2 2 times higher than ordinary fish oil capsules, and the enrichment rate is four times faster than common fish oil capsules.
  • FASTOMEGA™ belongs to liquid immune nutrients, and it is more convenient for enteral administration and absorption than ordinary fish oil capsules. It can quickly reduce the level of inflammatory cytokines, effectively decrease various complications caused by surgery, more suitable for perioperative use.
  • FASTOMEGA™ can be administrated orally, nasal feeding or through a nasogastric tube directly, or through the jejunum nutrition tube. Compared with the ordinary fish oil capsules, it is safer and with higher cost performance, and the overall hospital cost is lower.

(1) Lower the level of triglycerides, regulate lipid metabolism, help to improve the physiological indicators of dialysis patients;

(2) Decrease the level of pro-inflammatory mediators and cytokines, increase the number of immune cells, promote postoperative recovery;

(3) Reduce postoperative infection and other complications, shorten the hospital stay;

(4) Help to slow down weight loss, increase lean body mass, promote gastrointestinal function recovery;

(5) Reduce tumor cachexia, reduce the side effects of radiotherapy and chemotherapy;

(6) Promote vascular dilatation, reduce vascular resistance, help to improve the situation of blood pressure and blood flow of organ transplant patients;

7) Reduce cardiovascular events in patients with coronary artery disease;

8) Lessen the sepsis symptom of ICU patients such as those with severe trauma and pyemia; improve oxygenation status, reduce the use of ventilators, shorten ICU monitoring time and time of using therapeutic antibiotics, reduce systemic inflammatory reaction syndrome, and lower the incidence of organ dysfunction sequelae.

9) lower the level of oxidative stress and inflammatory reaction, and improve symptom of chronic diseases such as lung and prostate.

  1. FASTOMEGA™ is micron-sized emulsion, and it can be quickly absorbed by small intestine without need of emulsifying by bile, the highest enrichment concentration can be reached in about five days at a cellular level. There are 40 open and self-controlled clinical trials show that FASTOMEGA™ has reached the highest drug concentration (Cmax) in five days, and it is four times faster than ordinary Omega-3 polyunsaturated fatty acids capsules.
  2. Taking FASTOMEGA™ for less than two weeks, the baseline of plasma EPA content can be improved 8 times, and it 200% higher than ordinary omega-3 polyunsaturated fatty acids capsule in the placebo group. After 4 weeks of administration, the content of EPA and DHA increased to 300% and 56.5% respectively. The platelet omega-6 / omega-3 ratio decreased from nearly 10/1 to about 4/1 after taking for 28 days. Compared with common omega-3 polyunsaturated fatty acid soft capsules, the level of inflammation-related factors in surgical patients decreased more significantly, the ICU nursing time was shorter, and postoperative complications were less.

The FASTOMEGA™ final product is produced by an American company which is certified by the highest food quality and safety assessment in the world (SQF, Level 3). The raw materials were purified by FDA-certified cGMP API workshop. Adopt the world’s most advanced supercritical CO2 fluid extraction (SFE) and supercritical fluid chromatography (SFC) production process, to ensure the purification of Omega 3 polyunsaturated fatty acids without contacting oxygen and organic solvent under non-high temperature condition, thus protect the Omega 3 polyunsaturated fatty acids from the oxidation decomposition, microorganisms pollution, and heavy metal residue.

FASTOMEGA™ is mainly used as an enteral nutrient for oral taking or nasal feeding, and it has a variety of fruit flavor formulas.